HK1 and breast carcinoma: [96] reported that bone marrow‐derived macrophages (BMDMs) incubated with tumor extracts from breast cancer patients show elevated levels of Hexokinase‐2 and other glycolytic enzymes, indicating that breast cancer cells may increase rather than decrease glycolysis in macrophages and this reprogramming was associated with enhanced tumor progression.